Presentations Biomarkers for Alzheimer’s Disease Summit 2021: Use of Novel Biomarkers of P. Gingivalis Infection & Neuroinflammation in the GAIN Trial KOL Webinar Series Part 2: Innovations in in Alzheimer's Disease: Getting to the Root Cause of Neurodegeneration CRTX AAIC Symposium Presentation AAIC 2021 Poster Presentation: Increased Levels of Phospho-Tau217 in Neuron Cultures and CVN Mice Infected with P. Gingivalis AAIC 2021 Poster Presentation: An Update and Baseline Data From The Phase 2/3 Gain Trial of Atuzaginstat (COR388) KOL Webinar Series Part 1: Innovation in Periodontal Disease – A Major Unmet Medical Need IADR 2021 Poster Presentation: "Gingipain Inhibitors Penetrate And Inhibit Gingipains In Porphyromonas gingivalis Biofilms" (July 23, 2021) IADR 2021 Poster Presentation: "Novel lysine-gingipain inhibitor atuzaginstat (COR388) is efficacious in a mouse model of periodontal disease." (July 23, 2021) ASCP 2021 Poster Presentation: “An Update and Baseline Data from the Phase 2/3 Gain Trial of COR388 (Atuzaginstat) a Novel Bacterial Virulence Factor Inhibitor for the Treatment of Alzheimer’s Disease” (June 1-4, 2021) ASCP 2021 Oral Presentation: “An Update and Baseline Data from the Phase 2/3 Gain Trial of COR388 (Atuzaginstat) a Novel Bacterial Virulence Factor Inhibitor for the Treatment of Alzheimer’s Disease” (June 1-4, 2021)
Biomarkers for Alzheimer’s Disease Summit 2021: Use of Novel Biomarkers of P. Gingivalis Infection & Neuroinflammation in the GAIN Trial
KOL Webinar Series Part 2: Innovations in in Alzheimer's Disease: Getting to the Root Cause of Neurodegeneration
AAIC 2021 Poster Presentation: Increased Levels of Phospho-Tau217 in Neuron Cultures and CVN Mice Infected with P. Gingivalis
AAIC 2021 Poster Presentation: An Update and Baseline Data From The Phase 2/3 Gain Trial of Atuzaginstat (COR388)
IADR 2021 Poster Presentation: "Gingipain Inhibitors Penetrate And Inhibit Gingipains In Porphyromonas gingivalis Biofilms" (July 23, 2021)
IADR 2021 Poster Presentation: "Novel lysine-gingipain inhibitor atuzaginstat (COR388) is efficacious in a mouse model of periodontal disease." (July 23, 2021)
ASCP 2021 Poster Presentation: “An Update and Baseline Data from the Phase 2/3 Gain Trial of COR388 (Atuzaginstat) a Novel Bacterial Virulence Factor Inhibitor for the Treatment of Alzheimer’s Disease” (June 1-4, 2021)
ASCP 2021 Oral Presentation: “An Update and Baseline Data from the Phase 2/3 Gain Trial of COR388 (Atuzaginstat) a Novel Bacterial Virulence Factor Inhibitor for the Treatment of Alzheimer’s Disease” (June 1-4, 2021)
